Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Simó

Showing results (11-20 of 358) with videos related to

Pageof 36
Sort By:
Investigative Ophthalmology & Visual Science|May 17, 2017
Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative ApproachStela Vujosevic, Rafael Simó
Diabetes|May 24, 2017
GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?Rafael Simó, Cristina Hernández
Diabetologia|June 5, 2023
What else can we do to prevent diabetic retinopathy?Rafael Simó, Cristina Hernández
Neural Regeneration Research|October 16, 2023
Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegenerationRafael Simó, Cristina Hernández
Revista Espanola De Cardiologia (English Ed.)|September 24, 2016
New Treatments for Type 2 Diabetes Mellitus and Cardiovascular Disease. The Revolution Has BegunRafael Simó, Cristina Hernández
Annals of Translational Medicine|May 16, 2020
Looking for solutions to lung dysfunction in type 2 diabetesRafael Simó, Albert Lecube
Expert Opinion on Investigational Drugs|August 10, 2007
Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practiceCristina Hernández, Rafael Simó
Endocrine|December 15, 2011
Erythropoietin produced by the retina: its role in physiology and diabetic retinopathyCristina Hernández, Rafael Simó
Diabetes Care|July 30, 2009
Advances in the medical treatment of diabetic retinopathyRafael Simó, Cristina Hernández
Diabetes Care|June 29, 2004
Albumin excretion rate is not affected by asymptomatic urinary tract infection: a prospective studyCristina Hernández, Rafael Simó
Pageof 36

Showing results (11-20 of 358) with videos related to

Sort By:
Pageof 36
Investigative Ophthalmology & Visual Science|May 17, 2017
Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative ApproachStela Vujosevic, Rafael Simó
Diabetes|May 24, 2017
GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?Rafael Simó, Cristina Hernández
Diabetologia|June 5, 2023
What else can we do to prevent diabetic retinopathy?Rafael Simó, Cristina Hernández
Neural Regeneration Research|October 16, 2023
Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegenerationRafael Simó, Cristina Hernández
Revista Espanola De Cardiologia (English Ed.)|September 24, 2016
New Treatments for Type 2 Diabetes Mellitus and Cardiovascular Disease. The Revolution Has BegunRafael Simó, Cristina Hernández
Annals of Translational Medicine|May 16, 2020
Looking for solutions to lung dysfunction in type 2 diabetesRafael Simó, Albert Lecube
Expert Opinion on Investigational Drugs|August 10, 2007
Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practiceCristina Hernández, Rafael Simó
Endocrine|December 15, 2011
Erythropoietin produced by the retina: its role in physiology and diabetic retinopathyCristina Hernández, Rafael Simó
Diabetes Care|July 30, 2009
Advances in the medical treatment of diabetic retinopathyRafael Simó, Cristina Hernández
Diabetes Care|June 29, 2004
Albumin excretion rate is not affected by asymptomatic urinary tract infection: a prospective studyCristina Hernández, Rafael Simó
Pageof 36